• COVA Recruiting in Belgium, Brazil, France and US
  • COVA Completion of Part 1 patient enrollment (50 ) in January 2021
  • COVA Interim analysis of Part 1 (50 patients) in Q1 2021
  • COVA Approvals to start Part 2 in Q1 2021
  • COVA Interim analysis for Part 2 (155 patients) expected in Q3 2021
  • COVA Completion of patient enrollment (Part 2) expected in Q3 2021
  • COVA Final study results (Part 1 and Part 2) expected in Q4 2021
  • SARA-INT Patient enrollment in the USA and Belgium completed in March 2020
  • SARA-INT Last patient out (LPO) completed in Dec 2020
  • SARA-INT Positive topline study results in August 2021
  • SARA-INT Full study results to be communicated at ICFSR in September 2021